SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, compares potenti ...

Virologists and public health specialists have warned about the pandemic threat for years. H5N1, a problem in chickens for decades, first infected humans in 1997, in an outbreak in Hong Kong. Eighteen ...

As summer approaches, infectious diseases such as H5N1 — commonly known as bird flu — can spread more easily and potentially ...

The H5N1 strain of the Highly Pathogenic Avian Influenza continues to infect poultry in Arkansas and across the country.

Researchers identified a novel H5N1 clade 2.3.2.1e causing isolated brain infection in a child (1). Historically, Highly ...

Private financing of up to $60M offering of common stock (with $10M upfront) and milestone-based warrants expected to support operations into Q1 ...

Bird flu cases reported in parts of Maharashtra have triggered fresh public health concern, especially after infected poultry were detected in affected zones. While human infections remain rare, ...

Traws Pharma already develops antiviral drugs for influenza, H5N1 bird flu, and COVID-19. ・Hantavirus is a severe rodent-borne disease with a fatality rate of 30% to 50% in humans. ・The World Health ...

Traws Pharma is responding to the threat of Hantavirus, a rodent-borne negative-strand RNA virus that typically results in a 30-50% fatality rate when transmitted to humans and which has been ...

Dr. Rajeev Bahl confirms no human cases of H5N1 bird flu in Maharashtra despite recent outbreak. Expert insights on pandemic preparedness and the global impact of avian influenza.

While the disease primarily affects birds, health experts say certain strains of the virus, especially H5N1, can occasionally infect humans and cause severe illness.

The Infectious Diseases Society of America has updated its guidelines on antiviral use for adults with mild to moderate COVID-19, tailoring recommendations to patient risk profiles. Meanwhile, Moderna ...